Akero Therapeutics
AKRO
AKRO
168 hedge funds and large institutions have $2.09B invested in Akero Therapeutics in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 50 increasing their positions, 57 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
12% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 57
54% less call options, than puts
Call options by funds: $8.49M | Put options by funds: $18.6M
Holders
168
Holding in Top 10
5
Calls
$8.49M
Puts
$18.6M
Top Buyers
| 1 | +$79.8M | |
| 2 | +$37.4M | |
| 3 | +$19.8M | |
| 4 |
RI
RTW Investments
New York
|
+$14M |
| 5 |
PA
Perceptive Advisors
New York
|
+$6.17M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$19.4M | |
| 3 | -$14.3M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$13.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.7M |